EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Age-dependent bone mineral density responses to gender-affirming hormone therapy in transgender individuals: a one-year prospective study

Chiara Ceolin, Martina Dall'Agnol, Giulia Termini, Mario Virgilio Papa, Giulia Casali, Anna Bertocco, Alberto Scala, Sandro Giannini, Alberto Ferlin, Giuseppe Sergi, Andrea Garolla, Marina De Rui und 1 weitere

Journal of Endocrinological Investigation · 04.08.2025 · 48 (12) · 2879-2888

DOI: 10.1007/s40618-025-02675-5 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Endocrinological Investigation, online erschienen am 04.08.2025. Verfasst von Chiara Ceolin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Geriatrics Division, Department of Medicine (DIMED), University of Padua, Padua, Italy. chiara.ceolin.1@phd.unipd.it. Hauptthemen laut MEDLINE: Bone Density, Transgender Persons, Gender-Affirming Procedures, Hormone Replacement Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Evidence on the skeletal effects of gender-affirming hormone therapy (GAHT) in transgender individuals remains limited, especially across age groups. Individuals assigned male at birth (AMAB) often show reduced bone mineral density (BMD) even before GAHT, whereas findings in those assigned female at birth (AFAB) are more variable. Given the key role of adolescence and early adulthood in peak bone mass, timely skeletal assessment is essential. This study compared BMD before and after one year (1-y) of GAHT to age-matched cisgender controls.

Methods

Prospective observational study involving 269 adults (162 transgender and 107 cisgender controls) conducted at the University Hospital of Padua (January 2020-November 2024). Dual-energy X-ray absorptiometry (DXA) was performed at baseline and after 1-y of GAHT.

Results

After 1-y of GAHT, in AMAB individuals, lumbar spine BMD significantly increased (from 0.97 ± 0.16 to 1.02 ± 0.14 g/cm², p < 0.001), particularly in those under 20 years. AFAB individuals experienced a modest but significant reduction in femoral neck BMD (from 0.81 ± 0.12 to 0.79 ± 0.13, p < 0.05), especially in the 20–30-year age group. Age-stratified analyses revealed that younger participants showed greater BMD improvements, while those over 20 exhibited stable or declining values. Linear regression confirmed age as an independent predictor of BMD change, with older age associated with reduced skeletal responsiveness to GAHT at key femoral sites.

Conclusions

GAHT has variable effects on bone health, influenced by age and sex assigned at birth. Early initiation may favor bone accrual, especially in AMAB individuals, while AFAB individuals may require closer monitoring for site-specific bone loss during testosterone therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone DensityTransgender PersonsGender-Affirming ProceduresHormone Replacement TherapyTranssexualismHumansMaleFemaleAdultProspective StudiesYoung AdultAbsorptiometry, PhotonAdolescentAge FactorsMiddle AgedFollow-Up StudiesLumbar Vertebrae

Stichwörter der Autor:innen

BMDBoneGender incongruenceGender-Affirming hormone therapyTransgender

Autor:innen und Institutionen

  • Geriatrics Division, Department of Medicine (DIMED), University of Padua, Padua, Italy. chiara.ceolin.1@phd.unipd.it.
  • Department of Neurobiology, Care Sciences and Society, Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden. chiara.ceolin.1@phd.unipd.it.
  • Geriatrics Division, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Unit of Andrology and Reproductive Medicine, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Department of Medicine, Clinica Medica 1, University of Padua, Padua, Italy.

Zitieren

APA

Ceolin, C., Dall'Agnol, M., Termini, G., Papa, M. V., Casali, G., Bertocco, A., Scala, A., Giannini, S., Ferlin, A., Sergi, G., Garolla, A., De Rui, M., & GIIG group (2025). Age-dependent bone mineral density responses to gender-affirming hormone therapy in transgender individuals: a one-year prospective study. Journal of Endocrinological Investigation, 48(12), 2879-2888. https://doi.org/10.1007/s40618-025-02675-5

Vancouver

Ceolin C, Dall'Agnol M, Termini G, Papa MV, Casali G, Bertocco A, et al. Age-dependent bone mineral density responses to gender-affirming hormone therapy in transgender individuals: a one-year prospective study. Journal of Endocrinological Investigation. 2025;48(12):2879-2888. doi:10.1007/s40618-025-02675-5

BibTeX
@article{Ceolin2025,
  author = {Ceolin, Chiara and Dall'Agnol, Martina and Termini, Giulia and Papa, Mario Virgilio and Casali, Giulia and Bertocco, Anna and Scala, Alberto and Giannini, Sandro and Ferlin, Alberto and Sergi, Giuseppe and Garolla, Andrea and De Rui, Marina and GIIG group, GIIG group},
  title = {Age-dependent bone mineral density responses to gender-affirming hormone therapy in transgender individuals: a one-year prospective study},
  journal = {Journal of Endocrinological Investigation},
  year = {2025},
  volume = {48},
  number = {12},
  pages = {2879--2888},
  doi = {10.1007/s40618-025-02675-5}
}
Kostenlos starten →